These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38616440)

  • 1. HPV Vaccine Issues in Japan: A review of our attempts to promote the HPV vaccine and to provide effective evaluation of the problem through social-medical and behavioral-economic perspectives.
    Yagi A; Ueda Y; Kimura T
    Vaccine; 2024 Sep; 42(22):125859. PubMed ID: 38616440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation.
    Larson HJ; Wilson R; Hanley S; Parys A; Paterson P
    Hum Vaccin Immunother; 2014; 10(9):2543-50. PubMed ID: 25483472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of catch-up and routine program of the 9-valent vaccine on cervical cancer risk reduction in Japan.
    Yagi A; Nakagawa S; Ueda Y; Oka E; Ikeda S; Kakuda M; Kobayashi E; Ito Y; Katayama K; Hirai K; Nakayama T; Kimura T
    Cancer Sci; 2024 Mar; 115(3):916-925. PubMed ID: 38158850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The last strategy for re-dissemination of HPV vaccination in Japan while still under the suspension of the governmental recommendation.
    Ueda Y; Yagi A; Abe H; Nakagawa S; Minekawa R; Kuroki H; Miwa A; Kimura T
    Sci Rep; 2020 Sep; 10(1):16091. PubMed ID: 32999408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical Cancer Protection in Japan: Where Are We?
    Yagi A; Ueda Y; Kakuda M; Nakagawa S; Hiramatsu K; Miyoshi A; Kobayashi E; Kimura T; Kurosawa M; Yamaguchi M; Adachi S; Kudo R; Sekine M; Suzuki Y; Sukegawa A; Ikeda S; Miyagi E; Enomoto T; Kimura T
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A questionnaire survey on the prevention of HPV infection among females and males who came of age in Japan under various scenarios of HPV vaccine recommendation.
    Ishimoto T; Yagi A; Nakajima K; Okamoto N; Yukimitsu E; Kawasaki M; Kawae Y; Hayasaka S; Ueda Y; Kimura T
    Hum Vaccin Immunother; 2023 Aug; 19(2):2229222. PubMed ID: 37462048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The controversy on HPV vaccination in Japan: Criticism of the ethical validity of the arguments for the suspension of the proactive recommendation.
    Okita T; Enzo A; Kadooka Y; Tanaka M; Asai A
    Health Policy; 2020 Feb; 124(2):199-204. PubMed ID: 31924344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Even though active recommendation for HPV vaccination has restarted, Japan's rates have not recovered.
    Yagi A; Ueda Y; Oka E; Nakagawa S; Kimura T; Shimoya K
    Cancer Sci; 2024 Jul; 115(7):2410-2416. PubMed ID: 38698561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool.
    Hutubessy R; Levin A; Wang S; Morgan W; Ally M; John T; Broutet N
    BMC Med; 2012 Nov; 10():136. PubMed ID: 23146319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan.
    Nakagawa S; Ueda Y; Yagi A; Ikeda S; Hiramatsu K; Kimura T
    Cancer Sci; 2020 Jun; 111(6):2156-2162. PubMed ID: 32248632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study.
    Simms KT; Hanley SJB; Smith MA; Keane A; Canfell K
    Lancet Public Health; 2020 Apr; 5(4):e223-e234. PubMed ID: 32057317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of Japanese mothers on the effectiveness of the Ministry of Health, Labor and Welfare's revised HPV vaccine leaflet.
    Shiomi M; Ueda Y; Abe H; Yagi A; Sakiyama K; Kimura T; Tanaka Y; Ohmichi M; Ichimura T; Sumi T; Murata H; Okada H; Nakai H; Matsumura N; Saito J; Takagi T; Horikoshi Y; Shimura K
    Hum Vaccin Immunother; 2020 Oct; 16(10):2555-2558. PubMed ID: 32243236
    [No Abstract]   [Full Text] [Related]  

  • 13. Challenge to improve Japan's deplorable HPV vaccination rate by local government actions.
    Miyoshi A; Ueda Y; Yagi A; Kimura T; Kobayashi E; Tasaka K; Todo A; Matsunami K; Matsuoka T; Kimura T
    J Obstet Gynaecol Res; 2022 May; 48(5):1233-1239. PubMed ID: 35274421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study.
    Cody P; Tobe K; Abe M; Elbasha EH
    BMC Infect Dis; 2021 Jan; 21(1):11. PubMed ID: 33407188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus vaccination of the daughters of obstetricians and gynecologists in Japan.
    Egawa-Takata T; Ueda Y; Morimoto A; Tanaka Y; Matsuzaki S; Kobayashi E; Yoshino K; Sekine M; Enomoto T; Kimura T
    Int J Clin Oncol; 2016 Feb; 21(1):53-8. PubMed ID: 26155971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination.
    Morimoto A; Ueda Y; Egawa-Takata T; Yagi A; Terai Y; Ohmichi M; Ichimura T; Sumi T; Murata H; Kanzaki H; Nakai H; Mandai M; Yoshino K; Fujita M; Kimura T; Saito J; Sobue T; Nishikawa N; Sekine M; Enomoto T; Horikoshi Y; Takagi T
    Int J Clin Oncol; 2015 Jun; 20(3):549-55. PubMed ID: 25001869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.
    Novaes HM; de Soárez PC; Silva GA; Ayres A; Itria A; Rama CH; Sartori AM; Clark AD; Resch S
    Vaccine; 2015 May; 33 Suppl 1():A135-42. PubMed ID: 25919154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parental decision-making on
    Kobayashi KI; Chanyasanha C; Sujirarat D
    Int J Adolesc Med Health; 2020 Sep; 33(3):95-105. PubMed ID: 32304302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compensation programs after withdrawal of the recommendation for HPV vaccine in Japan.
    Yuji K; Nakada H
    Hum Vaccin Immunother; 2016 May; 12(5):1321-4. PubMed ID: 26513303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Papillomavirus Vaccination by Birth Fiscal Year in Japan.
    Yagi A; Ueda Y; Oka E; Nakagawa S; Kimura T
    JAMA Netw Open; 2024 Jul; 7(7):e2422513. PubMed ID: 39012629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.